HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 orNatronobacterium gregoryiArgonaute-Reference-Cited by-同舟云学术

HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 orNatronobacterium gregoryiArgonaute

Published:2018-05-18 Issue:7 Volume:5 Page:1700540
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Lao Yeh-Hsing¹,Li Mingqiang¹,Gao Madeleine A.¹,Shao Dan¹,Chi Chun-Wei²,Huang Dantong¹,Chakraborty Syandan¹,Ho Tzu-Chieh¹,Jiang Weiqian¹,Wang Hong-Xia¹,Wang Sihong²,Leong Kam W.¹³^ORCID

Affiliation:

1. Department of Biomedical Engineering; Columbia University; New York NY 10027 USA

2. Department of Biomedical Engineering; CUNY-City College of New York; New York NY 10031 USA

3. Department of Systems Biology; Columbia University Medical Center; New York NY 10032 USA

Funder

National Institutes of Health

Guangdong Innovative and Entrepreneurial Research Team Program

Global Research Laboratory Program, Korea

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Reference49 articles.

1. The new frontier of genome engineering with CRISPR-Cas9

2. Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation

3. Multiplex Genome Engineering Using CRISPR/Cas Systems

4. In vivo genome editing using Staphylococcus aureus Cas9

5. Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the evolving CRISPR/Cas9 for precision oncology;Journal of Translational Medicine;2024-08-08

2. Human vascular organoids with a mosaicAKT1mutation recapitulate Proteus syndrome;2024-01-27

3. Quaternary ammonium-tethered hyperbranched polyurea nanoassembly synergized with antibiotics for enhanced antimicrobial efficacy;Biomaterials Science;2024

4. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine;Genes & Diseases;2024-01

5. Biomaterial-Based CRISPR/Cas9 Delivery Systems for Tumor Treatment;Biomaterials Research;2024-01